Medicenna Therapeutics (MDNAF) Q3 2025 Earnings

31JulConfirmed
Q3 2024
Q4 2024
Q1 2025
Q3 2025
-0.05
-0.04
-0.04
-0.03

Details

Expected EPS
-0.04407
Actual EPS
-0.04407
Surprise EPS
0
Surprise Percent
+0%

Description

Medicenna Therapeutics (MDNAF) has reported earnings of -0.04407 per share for Q3 2025.

0 Comments

Share your thoughts